Emergent BioSolutions Inc (NYSE:EBS)

52.00
Delayed Data
As of May 18
 +1.36 / +2.69%
Today’s Change
29.15
Today|||52-Week Range
55.91
+11.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues450.1M522.8M488.8M560.9M
 
 
 
 
 
Cost of Goods Sold86.0M89.0M103.9M147.1M
 
 
 
 
 
Depreciation And Amortization32.5M35.3M38.2M40.8M
 
 
 
 
 
 
Operating ExpensesGross Income331.7M398.5M346.6M373.0M
 
 
 
 
 
General Expenses270.0M282.0M239.6M240.8M
 
 
 
 
 
Research And Development150.8M144.2M107.6M97.4M
 
 
 
 
 
Total Operating Expenses388.4M406.3M381.7M428.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income61.8M116.5M107.1M132.2M
 
 
 
 
 
Extraordinary Credit----10.9M0.00
 
 
Extraordinary Charge-3.7M-20.4M-12.4M-7.9M
 
 
 
 
 
Interest Expense On Debt10.7M9.4M9.8M8.8M
 
 
 
 
 
Other Expenses2.9M-319.0K263.0K-815.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income53.1M89.8M99.2M118.6M
 
 
 
 
 
Income Taxes-16.3M-26.9M-36.7M-36.0M
 
 
 
 
 
Discontinued Operations0.000.00-10.7M0.00
 
 
Net Income36.7M62.9M51.8M82.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS37.3M38.6M40.2M41.8M
 
 
 
 
 
Shares To Calculate EPS Diluted45.8M47.3M49.3M50.3M
 
 
 
 
 
 
Earnings Per ShareEPS$0.88$1.41$1.13$1.71
 
 
 
 
 
EPS Diluted$0.88$1.41$1.13$1.71